Catasys (CATS) Receiving Somewhat Negative News Coverage, Study Finds

News coverage about Catasys (NASDAQ:CATS) has been trending somewhat negative recently, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Catasys earned a media sentiment score of -0.07 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.4507361688309 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Several brokerages have commented on CATS. Taglich Brothers started coverage on Catasys in a research note on Wednesday, October 18th. They set a “speculative buy” rating and a $8.00 target price for the company. Telsey Advisory Group initiated coverage on Catasys in a report on Wednesday, October 18th. They issued a “buy” rating on the stock. ValuEngine cut Catasys from a “hold” rating to a “sell” rating in a report on Saturday, October 21st. Finally, Zacks Investment Research cut Catasys from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th.

Shares of Catasys (NASDAQ:CATS) traded down $0.07 on Thursday, hitting $3.82. The company had a trading volume of 19,600 shares, compared to its average volume of 51,071. Catasys has a 12 month low of $3.30 and a 12 month high of $14.00. The company has a market cap of $61.81, a PE ratio of -3.71 and a beta of -0.33.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at

Catasys Company Profile

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Insider Buying and Selling by Quarter for Catasys (NASDAQ:CATS)

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with's FREE daily email newsletter.

Leave a Reply